People
-
Aerami Therapeutics has announced the promotion of Joshua Ziel from Chief of Staff and VP, Program Development to Chief Operating Officer and interim CEO. Executive Chairwoman Anne Whitaker had been leading Aerami since the sudden… Read more . . .
-
Inhaled drug developer MannKind Corporation has announced the appointment of former Acorda Therapeutics Head of R&D and Chief Medical Officer Burkhard Blank as MannKind’s new Executive VP, Research & Development, and Chief Medical Officer. At Acorda, he… Read more . . .
-
Inhaler testing equipment maker Copley Scientific has announced the appointment of Clair Brooks as Applications Specialist “to maintain a customer-centric focus as growth continues.” Brooks was most recently a field application specialist at Primerdesign, a… Read more . . .
-
Aerami Therapeutics has issued a statement following the death of CEO Lisa Yañez, who was killed in a car accident on May 2, 2023 in Chapel Hill, NC, USA, offering condolences to Yañez’s family and… Read more . . .
-
ReCode Therapeutics, which is developing inhaled mRNA therapeutics for the treatment of primary ciliary dyskinesia and cystic fibrosis, has named John G. Matthews as Senior VP of Clinical Development. ReCode initiated a Phase 1 trial… Read more . . .
-
HCmed Innovations announced that former AstraZeneca Science and Innovation Director of Inhaled Drug Delivery Gunilla Petersson has joined the company as Chief Scientific Officer. Petersson has almost 30 years of experience in the pharmaceutical industry, primarily… Read more . . .
-
Former Arranta Bio CEO David Stevens has joined CDMO Kindeva Drug Delivery as Chief Commercial Officer, the company said. Prior to Arranta, Stevens held a variety of roles at Albany Molecular Research, Aptuit, and Charles… Read more . . .
-
MannKind Corporation has named former Acorda Therapeutics COO Lauren Sabella as Executive VP, Chief Operating Officer. Sabella’s experience includes 12 years at Acorda, first as Chief Commercial Officer and then as COO; she previously served in a… Read more . . .
-
Charles G. Thiel, one of the most influential scientists working in respiratory drug delivery over the past 7 decades, passed away on March 10, 2023 at the age of 94. In 1956, Thiel and co-workers… Read more . . .
-
Utuly intranasal epinephrine developer Bryn Pharma has named Sandy Loreaux as CEO, succeeding David Dworaczyk, who will remain with the company as head of R&D, regulatory, and production. Loreaux was most recently US President of… Read more . . .
Upcoming Events
Sponsored by Intertek
Want information about upcoming OINDP-related events delivered directly to your inbox? click here
September 15-September 18: DDL New Researcher Network Summer Event, London, UK
September 16-September 17: IPAC-RS 2026 Nasal Innovation Forum, Jersey City, NJ, USA
September 24-September 25: Inhaled & Nasal Biologics | DNA Forum, Cambridge, UK
October 14-October 15: Advancing Bioequivalence Frameworks for Inhalation and Nasal Drug Products: Optimizing In Vitro, In Vivo, and In Silico Methods, Rockville, MD, USA
October 19-October 20: MVIC Autumn Training 2026, Lund, Sweden